477 related articles for article (PubMed ID: 22828946)
1. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
[TBL] [Abstract][Full Text] [Related]
2. Anti-sRAGE autoimmunity in obesity: downturn after bariatric surgery is independent of previous diabetic status.
Lorenzi R; Pattou F; Beuscart JB; Grossin N; Lambert M; Fontaine P; Caiazzo R; Pigeyre M; Patrice A; Daroux M; Boulanger E; Dubucquoi S
Diabetes Metab; 2014 Nov; 40(5):356-62. PubMed ID: 24933232
[TBL] [Abstract][Full Text] [Related]
3. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
4. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss.
Brix JM; Stingl H; Höllerl F; Schernthaner GH; Kopp HP; Schernthaner G
J Clin Endocrinol Metab; 2010 Nov; 95(11):4877-81. PubMed ID: 20660040
[TBL] [Abstract][Full Text] [Related]
5. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
[TBL] [Abstract][Full Text] [Related]
7. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
Schernthaner GH; Kopp HP; Kriwanek S; Krzyzanowska K; Satler M; Koppensteiner R; Schernthaner G
Obes Surg; 2006 Jun; 16(6):709-15. PubMed ID: 16756729
[TBL] [Abstract][Full Text] [Related]
8. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
9. Early insulin sensitivity after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels.
van Dielen FM; Nijhuis J; Rensen SS; Schaper NC; Wiebolt J; Koks A; Prakken FJ; Buurman WA; Greve JW
Surg Obes Relat Dis; 2010; 6(4):340-4. PubMed ID: 20096645
[TBL] [Abstract][Full Text] [Related]
10. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
13. The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis.
Moser B; Bekos C; Zimprich F; Nickl S; Klepetko W; Ankersmit J
Biochem Biophys Res Commun; 2012 Mar; 420(1):96-101. PubMed ID: 22405771
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.
Baena-Fustegueras JA; Pardina E; Balada E; Ferrer R; Catalán R; Rivero J; Casals I; Lecube A; Fort JM; Vargas V; Peinado-Onsurbe J
JAMA Surg; 2013 Feb; 148(2):151-6. PubMed ID: 23426590
[TBL] [Abstract][Full Text] [Related]
15. Endothelial activation markers and their key regulators after restrictive bariatric surgery.
Nijhuis J; van Dielen FM; Fouraschen SM; van den Broek MA; Rensen SS; Buurman WA; Greve JW
Obesity (Silver Spring); 2007 Jun; 15(6):1395-9. PubMed ID: 17557976
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
17. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects.
Golpaie A; Tajik N; Masoudkabir F; Karbaschian Z; Talebpour M; Hoseini M; Hosseinzadeh-Attar MJ
Eur Cytokine Netw; 2011 Dec; 22(4):181-6. PubMed ID: 22266100
[TBL] [Abstract][Full Text] [Related]
18. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
19. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
[TBL] [Abstract][Full Text] [Related]
20. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
